{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:30:46Z","timestamp":1792791046704,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This research was supported by the grant from National Research Foundation of Korea (NRF) grant funded by the Korea government","award":["2020R1G1A1006948"],"award-info":[{"award-number":["2020R1G1A1006948"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Uncontrolled diabetes has been associated with progression of diabetic retinopathy (DR) in several studies. Therefore, we aimed to investigate systemic and ophthalmic factors related to worsening of DR even after completion of panretinal photocoagulation (PRP). We retrospectively reviewed DR patients who had completed PRP in at least one eye with a 3-year follow-up. A total of 243 eyes of 243 subjects (mean age 52.6\u2009\u00b1\u200911.6\u00a0years) were enrolled. Among them, 52 patients (21.4%) showed progression of DR after PRP (progression group), and the other 191 (78.6%) patients had stable DR (non-progression group). The progression group had higher proportion of proliferative DR (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.019); lower baseline visual acuity (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001); and higher platelet count (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.048), hemoglobin (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.044), and hematocrit, (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.042) than the non-progression group. In the multivariate logistic regression analysis for progression of DR, baseline visual acuity (HR: 0.053,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001) and platelet count (HR: 1.215,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.031) were identified as risk factors for progression. Consequently, we propose that patients with low visual acuity or high platelet count are more likely to have progressive DR despite PRP and require careful observation. Also, the evaluation of hemorheological factors including platelet counts before PRP can be considered useful in predicting the prognosis of DR.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-93384-5","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T06:04:04Z","timestamp":1625465044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Risk factors associated with progression of diabetic retinopathy in eyes treated with panretinal photocoagulation"],"prefix":"10.1038","volume":"11","author":[{"given":"Sung Uk","family":"Baek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Seon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bum-Joo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soonil","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,5]]},"reference":[{"key":"93384_CR1","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1001\/jama.290.15.2057","volume":"290","author":"NG Congdon","year":"2003","unstructured":"Congdon, N. G., Friedman, D. S. & Lietman, T. Important causes of visual impairment in the world today. JAMA 290, 2057\u20132060. https:\/\/doi.org\/10.1001\/jama.290.15.2057 (2003).","journal-title":"JAMA"},{"key":"93384_CR2","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.2337\/diacare.26.9.2653","volume":"26","author":"TA Ciulla","year":"2003","unstructured":"Ciulla, T. A., Amador, A. G. & Zinman, B. Diabetic retinopathy and diabetic macular edema: Pathophysiology, screening, and novel therapies. Diabetes Care 26, 2653\u20132664. https:\/\/doi.org\/10.2337\/diacare.26.9.2653 (2003).","journal-title":"Diabetes Care"},{"key":"93384_CR3","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2337\/dc15-2171","volume":"39","author":"JL Leasher","year":"2016","unstructured":"Leasher, J. L. et al. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: A meta-analysis from 1990 to 2010. Diabetes Care 39, 1643\u20131649. https:\/\/doi.org\/10.2337\/dc15-2171 (2016).","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"93384_CR4","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.2337\/diacare.26.2007.s99","volume":"26","author":"DS Fong","year":"2003","unstructured":"Fong, D. S. et al. Diabetic retinopathy. Diabetes Care 26(Suppl 1), S99\u2013S102. https:\/\/doi.org\/10.2337\/diacare.26.2007.s99 (2003).","journal-title":"Diabetes Care"},{"key":"93384_CR5","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s00125-009-1450-4","volume":"52","author":"J Grauslund","year":"2009","unstructured":"Grauslund, J., Green, A. & Sjolie, A. K. Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients. Diabetologia 52, 1829\u20131835. https:\/\/doi.org\/10.1007\/s00125-009-1450-4 (2009).","journal-title":"Diabetologia"},{"key":"93384_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0002-9394(76)90292-0","volume":"81","author":"The Diabetic Retinopathy Study Research Group","year":"1976","unstructured":"The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am. J. Ophthalmol. 81, 383\u2013396. https:\/\/doi.org\/10.1016\/0002-9394(76)90292-0 (1976).","journal-title":"Am. J. Ophthalmol."},{"key":"93384_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000098499","volume":"39","author":"GE Lang","year":"2007","unstructured":"Lang, G. E. Laser treatment of diabetic retinopathy. Dev. Ophthalmol. 39, 48\u201368. https:\/\/doi.org\/10.1159\/000098499 (2007).","journal-title":"Dev. Ophthalmol."},{"key":"93384_CR8","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ophtha.2016.12.005","volume":"124","author":"SB Bressler","year":"2017","unstructured":"Bressler, S. B. et al. Factors associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab. Ophthalmology 124, 431\u2013439. https:\/\/doi.org\/10.1016\/j.ophtha.2016.12.005 (2017).","journal-title":"Ophthalmology"},{"key":"93384_CR9","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1080\/02713683.2020.1712729","volume":"45","author":"T Bek","year":"2020","unstructured":"Bek, T. Incidence and risk for developing proliferative diabetic retinopathy after photocoagulation for diabetic maculopathy. Curr Eye Res. 45, 986\u2013991. https:\/\/doi.org\/10.1080\/02713683.2020.1712729 (2020).","journal-title":"Curr Eye Res."},{"key":"93384_CR10","doi-asserted-by":"publisher","first-page":"17233","DOI":"10.1038\/s41598-020-74184-9","volume":"10","author":"J Kim","year":"2020","unstructured":"Kim, J., Park, I. W. & Kwon, S. Factors predicting final visual outcome in quiescent proliferative diabetic retinopathy. Sci. Rep. 10, 17233. https:\/\/doi.org\/10.1038\/s41598-020-74184-9 (2020).","journal-title":"Sci. Rep."},{"key":"93384_CR11","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.ophtha.2019.06.016","volume":"126","author":"Z Sun","year":"2019","unstructured":"Sun, Z. et al. OCT angiography metrics predict progression of diabetic retinopathy and development of diabetic macular edema: A prospective study. Ophthalmology 126, 1675\u20131684. https:\/\/doi.org\/10.1016\/j.ophtha.2019.06.016 (2019).","journal-title":"Ophthalmology"},{"key":"93384_CR12","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/eye.2009.108","volume":"23","author":"TM Curtis","year":"2009","unstructured":"Curtis, T. M., Gardiner, T. A. & Stitt, A. W. Microvascular lesions of diabetic retinopathy: Clues towards understanding pathogenesis?. Eye (Lond.) 23, 1496\u20131508. https:\/\/doi.org\/10.1038\/eye.2009.108 (2009).","journal-title":"Eye (Lond.)"},{"key":"93384_CR13","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.2337\/diacare.24.8.1476","volume":"24","author":"AI Vinik","year":"2001","unstructured":"Vinik, A. I., Erbas, T., Park, T. S., Nolan, R. & Pittenger, G. L. Platelet dysfunction in type 2 diabetes. Diabetes Care 24, 1476\u20131485. https:\/\/doi.org\/10.2337\/diacare.24.8.1476 (2001).","journal-title":"Diabetes Care"},{"key":"93384_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.18240\/ijo.2019.08.04","volume":"12","author":"W-J Luo","year":"2019","unstructured":"Luo, W.-J. & Zhang, W.-F. The relationship of blood cell-associated inflammatory indices and diabetic retinopathy: A meta-analysis and systematic review. Int. J. Ophthalmol. 12, 312 (2019).","journal-title":"Int. J. Ophthalmol."},{"key":"93384_CR15","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.5858\/133.9.1441","volume":"133","author":"G Lippi","year":"2009","unstructured":"Lippi, G. et al. Increased mean platelet volume in patients with acute coronary syndromes. Arch. Pathol. Lab. Med. 133, 1441\u20131443 (2009).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"93384_CR16","first-page":"182","volume":"4","author":"Z-L Zhong","year":"2011","unstructured":"Zhong, Z.-L., Han, M. & Chen, S. Risk factors associated with retinal neovascularization of diabetic retinopathy in type 2 diabetes mellitus. Int. J. Ophthalmol. 4, 182 (2011).","journal-title":"Int. J. Ophthalmol."},{"key":"93384_CR17","first-page":"84","volume":"9","author":"A Buch","year":"2017","unstructured":"Buch, A., Kaur, S., Nair, R. & Jain, A. Platelet volume indices as predictive biomarkers for diabetic complications in Type 2 diabetic patients. J. Lab. Phys. 9, 84 (2017).","journal-title":"J. Lab. Phys."},{"key":"93384_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jbspin.2007.06.016","volume":"75","author":"B Kisacik","year":"2008","unstructured":"Kisacik, B. et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 75, 291\u2013294 (2008).","journal-title":"Joint Bone Spine"},{"key":"93384_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.11613\/BM.2012.006","volume":"22","author":"S Margetic","year":"2012","unstructured":"Margetic, S. Inflammation and hemostasis. Biochem. Med. 22, 49\u201362 (2012).","journal-title":"Biochem. Med."},{"key":"93384_CR20","first-page":"28","volume":"14","author":"E Vagdatli","year":"2010","unstructured":"Vagdatli, E. et al. Platelet distribution width: A simple, practical and specific marker of activation of coagulation. Hippokratia 14, 28 (2010).","journal-title":"Hippokratia"},{"key":"93384_CR21","doi-asserted-by":"crossref","unstructured":"Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98, 766\u2013785 (1991).","DOI":"10.1016\/S0161-6420(13)38011-7"},{"key":"93384_CR22","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41433-019-0617-6","volume":"34","author":"Y Li","year":"2020","unstructured":"Li, Y., Yu, Y. & VanderBeek, B. L. Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy. Eye (Lond.) 34, 934\u2013941. https:\/\/doi.org\/10.1038\/s41433-019-0617-6 (2020).","journal-title":"Eye (Lond.)"},{"key":"93384_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000484275","volume":"192","author":"A Trevino-Becerra","year":"2018","unstructured":"Trevino-Becerra, A. Uric acid: The unknown uremic toxin. Contrib. Nephrol. 192, 25\u201333. https:\/\/doi.org\/10.1159\/000484275 (2018).","journal-title":"Contrib. Nephrol."},{"key":"93384_CR24","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/ceo.12990","volume":"45","author":"S Srinivasan","year":"2017","unstructured":"Srinivasan, S., Raman, R., Kulothungan, V., Swaminathan, G. & Sharma, T. Influence of serum lipids on the incidence and progression of diabetic retinopathy and macular oedema: Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular genetics Study-II. Clin. Exp. Ophthalmol. 45, 894\u2013900. https:\/\/doi.org\/10.1111\/ceo.12990 (2017).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"93384_CR25","unstructured":"Chelico, J. D., Wilcox, A. B., Vawdrey, D. K. & Kuperman, G. J. AMIA Annual Symposium Proceedings. 381 (American Medical Informatics Association)."},{"key":"93384_CR26","doi-asserted-by":"publisher","first-page":"e0220880","DOI":"10.1371\/journal.pone.0220880","volume":"14","author":"B-J Cho","year":"2019","unstructured":"Cho, B.-J. et al. Comparison of systemic conditions at diagnosis between central retinal vein occlusion and branch retinal vein occlusion. PLoS ONE 14, e0220880 (2019).","journal-title":"PLoS ONE"},{"key":"93384_CR27","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3389\/fneur.2017.00526","volume":"8","author":"S-H Lee","year":"2017","unstructured":"Lee, S.-H., Lee, J.-J., Kwon, Y., Kim, J.-H. & Sohn, J.-H. clinical implications of associations between headache and gastrointestinal disorders: A study using the Hallym Smart Clinical Data Warehouse. Front. Neurol. 8, 526 (2017).","journal-title":"Front. Neurol."},{"key":"93384_CR28","doi-asserted-by":"publisher","unstructured":"Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology. 98, 741\u2013756. https:\/\/doi.org\/10.1016\/s0161-6420(13)38009-9 (1991).","DOI":"10.1016\/s0161-6420(13)38009-9"},{"key":"93384_CR29","doi-asserted-by":"crossref","unstructured":"Group, E. T. D. R. S. R. Grading diabetic retinopathy from stereoscopic color fundus photographs\u2014An extension of the modified Airlie House classification: ETDRS report number 10. Ophthalmology 98, 786-806 (1991).","DOI":"10.1016\/S0161-6420(13)38012-9"},{"key":"93384_CR30","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ophtha.2015.11.004","volume":"123","author":"KE Kim","year":"2016","unstructured":"Kim, K. E. et al. Prevalence, awareness, and risk factors of primary open-angle glaucoma: Korea National Health and Nutrition Examination Survey 2008\u20132011. Ophthalmology 123, 532\u2013541 (2016).","journal-title":"Ophthalmology"},{"key":"93384_CR31","doi-asserted-by":"crossref","unstructured":"Group, E. T. D. R. S. R. Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report number 11. Ophthalmology 98, 807-822 (1991).","DOI":"10.1016\/S0161-6420(13)38013-0"},{"key":"93384_CR32","doi-asserted-by":"crossref","unstructured":"Boyer, D. S. et al. Outcomes with as-needed ranibizumab after initial monthly therapy: long-term outcomes of the phase III RIDE and RISE trials. Ophthalmology 122, 2504\u20132513. e2501 (2015).","DOI":"10.1016\/j.ophtha.2015.08.006"},{"key":"93384_CR33","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1001\/archophthalmol.2012.1043","volume":"130","author":"MS Ip","year":"2012","unstructured":"Ip, M. S., Domalpally, A., Hopkins, J. J., Wong, P. & Ehrlich, J. S. Long-term effects of ranibizumab on diabetic retinopathy severity and progression. Arch. Ophthalmol. 130, 1145\u20131152 (2012).","journal-title":"Arch. Ophthalmol."},{"key":"93384_CR34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ophtha.2014.08.048","volume":"122","author":"MS Ip","year":"2015","unstructured":"Ip, M. S., Domalpally, A., Sun, J. K. & Ehrlich, J. S. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy. Ophthalmology 122, 367\u2013374 (2015).","journal-title":"Ophthalmology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93384-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93384-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93384-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T05:38:35Z","timestamp":1670045915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93384-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,5]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["93384"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-93384-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-311086\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,5]]},"assertion":[{"value":"9 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13850"}}